Key Movements in the Stock Market and Business World on September 22, 2025

Scalping: Scalping is a trading style that focuses on profiting from tiny price movements. In this strategy, traders look for small profits in a very short time frame, and a 3 PIP move can be a target. This type of trading requires precise execution and quick decision-making.
Day Trading: Day trading is another strategy that involves monitoring short-term price movements, where traders seek to profit from minor fluctuations. Traders may use the 3 PIP target to enter or exit positions based on short-term trends.

Income Stocks to Watch

On September 22, 2025, the financial landscape saw notable activity in the income stocks sector. Companies such as SFNC, NEM, and MAS were highlighted as strong buys, according to Zacks Rank. This recognition could be indicative of robust financial health and promising dividend prospects, making them attractive to income-focused investors.

Technological and Energy Sector Developments

In the realm of technology and energy, significant strides were made. Peraso Inc. announced compliance with Nasdaq's minimum bid price requirement, potentially stabilizing its market position. Meanwhile, Revolve Renewable Power Corp expanded its portfolio by acquiring a 30MWp solar project in Canada, emphasizing the growing shift towards renewable energy in North American markets.

Healthcare and Pharmaceutical Innovations

The healthcare sector also saw remarkable advancements. MIRA Pharmaceuticals reported favorable results from a Phase 1 study of Ketamir-2, a next-generation ketamine analog, underscoring potential breakthroughs in treatment methodologies. Additionally, Allarity Therapeutics presented promising clinical data for Stenoparib/2X-121, offering new hope for ovarian cancer patients with its extended median overall survival rates.

Corporate Announcements and Expansions

Several corporations announced major initiatives. Classover Holdings revealed a GPU infrastructure upgrade to bolster its AI-driven educational programs. Cosmos Health commenced U.S. operations, targeting the lucrative nutraceuticals market. Furthermore, CEA Industries initiated a substantial $250 million stock buyback program, reflecting confidence in their financial strategies and future market performance.